Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression
The molecular programs that underlie progression in multiple myeloma (MM) are incompletely understood. Here the authors use a mouse model of MM and single-cell RNA-seq to define subclonal expression programs that arise during progression and that inform targeted therapeutic strategies.
Guardado en:
Autores principales: | Danielle C. Croucher, Laura M. Richards, Serges P. Tsofack, Daniel Waller, Zhihua Li, Ellen Nong Wei, Xian Fang Huang, Marta Chesi, P. Leif Bergsagel, Michael Sebag, Trevor J. Pugh, Suzanne Trudel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ed0c77588914674a20dc3c48bc248a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
por: Stephan M. Tirier, et al.
Publicado: (2021) -
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
por: Olena Kis, et al.
Publicado: (2017) -
Combating subclonal evolution of resistant cancer phenotypes
por: Samuel W. Brady, et al.
Publicado: (2017) -
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
por: Mihriban Karaayvaz, et al.
Publicado: (2018) -
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression
por: Arianna Calcinotto, et al.
Publicado: (2018)